ATAI Life Sciences Investor
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Headquarters:
Munich, Bayern, Germany
Last Funding Type:
Post-IPO Debt
Investors Number:
38.0
Last Funding Date:
2022-08-15
Acquisitions Number:
Made Acquisitions
Employee Number:
11-50
Total Funding:
522100000.0
Founded Date:
2018-01-01
Investment Stage:
Early Stage Venture, Late Stage Venture, Private Equity, Seed
Technology:
Mental Health Telecare
Estimated Revenue:
$1M to $10M
Investor Type:
Corporate Venture Capital
Number Of Exists:
2
Industry:
Blockchian and Crypto
Funding Status:
IPO